Expertise in
6
conditions

Bojan Vrtovec

Ljubljana, SI 
Expertise in
6
conditions
Ljubljana, SI 
OverviewLocationsClinical Research

Overview

Bojan Vrtovec practices in Ljubljana, Slovenia. Mr. Vrtovec is highly rated in 6 conditions, according to our data. His top areas of expertise are Dilated Cardiomyopathy (DCM), Heart Failure, Cardiomyopathy, Heart Transplant, and Lung Transplant.

His clinical research consists of co-authoring 87 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Ljubljana, 1000, Slovenia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients With IRon Deficiency and Chronic Heart Failure
Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients With IRon Deficiency and Chronic Heart Failure
Enrollment Status: Completed
Publish Date: January 28, 2025
Intervention Type: Drug
Study Drug: Iron
Study Phase: Phase 4
Thoratec Corporation HeartMate PHP™ Cardiogenic Shock Trial
Thoratec Corporation HeartMate PHP™ Cardiogenic Shock Trial
Enrollment Status: Terminated
Publish Date: July 21, 2023
Intervention Type: Device
Study Phase: Not Applicable
A PILOT TRIAL OF CELL THERAPY IN HEART FAILURE WITH PRESERVED EJECTION FRACTION
A PILOT TRIAL OF CELL THERAPY IN HEART FAILURE WITH PRESERVED EJECTION FRACTION
Enrollment Status: Completed
Publish Date: May 10, 2023
Intervention Type: Biological
Study Drug: Cell Therapy
Study Phase: Phase 2
Effects of Ranolazine on Myocardial Perfusion in Patients With Dilated Cardiomyopathy
Effects of Ranolazine on Myocardial Perfusion in Patients With Dilated Cardiomyopathy
Enrollment Status: Completed
Publish Date: April 28, 2021
Intervention Type: Drug
Study Phase: Phase 2
Repetitive Intramyocardial CD34+ Cell Therapy in Dilated Cardiomyopathy
Repetitive Intramyocardial CD34+ Cell Therapy in Dilated Cardiomyopathy
Enrollment Status: Completed
Publish Date: January 23, 2018
Intervention Type: Biological
Study Phase: Phase 2/Phase 3
View 4 Less Clinical Trials

87 Total Publications

SGLT2 Inhibitors Are Associated with Left Ventricular Reverse Remodeling in Patients with Non-Compaction Cardiomyopathy-A Prospective Observational Cohort Trial.
SGLT2 Inhibitors Are Associated with Left Ventricular Reverse Remodeling in Patients with Non-Compaction Cardiomyopathy-A Prospective Observational Cohort Trial.
Journal: Biomedicines
Published: September 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Vrtovec's expertise for a condition
ConditionClose
    View All 9 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile